Sanofi

Sanofi

@sanofi

Followers132K
Following250

Sanofi is a global life sciences company, focused on patient needs. Interactions with this account must comply with the Terms. https://t.co/XtTQuqnMnj

Paris
Joined on April 27, 2009
Statistics

We looked inside some of the tweets by @sanofi and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
6 hours
Average replies
2
Average retweets
5
Average likes
28
Tweets with photos
50 / 100
Tweets with videos
5 / 100
Tweets with links
0 / 100

Rankings (sorted by number of followers)

1. in country France and category HealthCare

12. in category HealthCare

56. in country France and category Brands

979. in country France

Sanofi
13 hours ago
Jean-Baptiste de Chatillon, Sanofi’s Chief Financial Officer, highlights Sanofi’s progress on cost cutting, at the Bernstein Annual Strategic Decisions CEO Conference. https://t.co/IOb4GR41sq

Jean-Baptiste de Chatillon, Sanofi’s Chief Financial Officer, highlights Sanofi’s progress on cost cutting, at the Bernstein Annual Strategic Decisions CEO Conference. https://t.co/IOb4GR41sq

Sanofi
15 hours ago
Live from the 2020 Bernstein European Strategic Decisions Conference: Sanofi’s CEO Paul Hudson shared the company’s progress over the last twelve months. https://t.co/JkWsmZh12j

Live from the 2020 Bernstein European Strategic Decisions Conference: Sanofi’s CEO Paul Hudson shared the company’s progress over the last twelve months. https://t.co/JkWsmZh12j

Sanofi
15 hours ago

Given the impact of climate change on health, our goal is to achieve carbon neutrality by 2050. Find out more about our commitment to the planet: https://t.co/dI4Hd9tmEE

Sanofi
15 hours ago
In June, the Science Based Targets initiative @sciencetargets approved our target to reduce our direct emissions, in line with limiting global warming to 1.5°C. https://t.co/REekYRydo3

In June, the Science Based Targets initiative @sciencetargets approved our target to reduce our direct emissions, in line with limiting global warming to 1.5°C. https://t.co/REekYRydo3

Sanofi
15 hours ago
Sanofi has joined the #RE100 initiative to source 100% renewable electricity across our global operations by 2030, part of our ambition to achieve carbon neutrality by 2050. https://t.co/irijP9FEEI
#ClimateWeekNYC @theRE100 @ClimateGroup https://t.co/Z7KOtVDPYY

Sanofi has joined the #RE100 initiative to source 100% renewable electricity across our global operations by 2030, part of our ambition to achieve carbon neutrality by 2050. https://t.co/irijP9FEEI #ClimateWeekNYC @theRE100 @ClimateGroup https://t.co/Z7KOtVDPYY

Sanofi
2 days ago
To #FightCOVID19, Sanofi and @GSK are committed to making the vaccine available globally.
Following supply agreements with the US, UK and @EU_Commission, we also announce an agreement with @Canada: https://t.co/2vPOUxeJXv
#SanofiActs https://t.co/rc57ae2qSW

To #FightCOVID19, Sanofi and @GSK are committed to making the vaccine available globally. Following supply agreements with the US, UK and @EU_Commission, we also announce an agreement with @Canada: https://t.co/2vPOUxeJXv #SanofiActs https://t.co/rc57ae2qSW

Sanofi
2 days ago

As part of our Asthma Realities series on #TheNextBreath, we’ve taken a closer look at what well-controlled #asthma can look like and what it can mean for people with the disease: https://t.co/PntZyXNgHJ

Sanofi
2 days ago

At the @Europarl_EN today, Thomas Triomphe, @SanofiPasteur Executive President, discussed Sanofi’s ongoing fight against #COVID19. Learn more about how we tackle challenges around vaccine production and distribution: https://t.co/WYeys8TA2E

Sanofi
2 days ago

Helping people living with cancer has always been one our key focuses at Sanofi. Our Global Head of Oncology, Alex Zehnder, shares more about Sanofi’s commitment to supporting patients throughout every stage of their cancer journey. #ESMO20

Sanofi
3 days ago
How do protein degraders take advantage of the body's recycling machinery, and could they help Sanofi scientists target tumors? Find out in this short audio overview: https://t.co/BWud7YvODU
#oncology https://t.co/0bfmVAgLco

How do protein degraders take advantage of the body's recycling machinery, and could they help Sanofi scientists target tumors? Find out in this short audio overview: https://t.co/BWud7YvODU #oncology https://t.co/0bfmVAgLco

Sanofi
3 days ago

With 18 million #cancer patients worldwide, we’re focused on addressing critical gaps that may help advance the care of these difficult-to-treat cancers. We are presenting our latest oncology developments at @myESMO. #ESMO20

Sanofi
3 days ago
#Immunotherapy news from #ESMO20: with @Regeneron, we presented pivotal trial data in first-line advanced Non-Small Cell Lung Cancer (NSCLC). Read more: https://t.co/S8xY2oOQ05 https://t.co/JHnY6HkRD2

#Immunotherapy news from #ESMO20: with @Regeneron, we presented pivotal trial data in first-line advanced Non-Small Cell Lung Cancer (NSCLC). Read more: https://t.co/S8xY2oOQ05 https://t.co/JHnY6HkRD2

Sanofi
3 days ago
In advancing the #GlobalGoals set by the @UN, multilateralism is key.
We are proud to announce that Sanofi CEO Paul Hudson has signed the UN @globalcompact Statement from Business Leaders for Renewed Global Cooperation. https://t.co/XjbVEdN18M
#UnitingBusiness https://t.co/QdqezJGWqg

In advancing the #GlobalGoals set by the @UN, multilateralism is key. We are proud to announce that Sanofi CEO Paul Hudson has signed the UN @globalcompact Statement from Business Leaders for Renewed Global Cooperation. https://t.co/XjbVEdN18M #UnitingBusiness https://t.co/QdqezJGWqg

Sanofi
3 days ago

At #ESMO20, we are presenting new research that details how studying biomarkers may help advance treatments for metastatic #BreastCancer patients.

Sanofi
4 days ago

Although #COVID19 has introduced new hurdles and challenges, we continue to focus on #ClinicalTrials and ensure patients don’t experience disruptions in their treatment and care. #ESMO20

Sanofi
5 days ago

Globally, an estimated 1.3 million men have been diagnosed with prostate cancer in the last five years. We are presenting our latest data in this disease at #ESMO20

Sanofi
5 days ago

#ESMO20 kicks off today! Head to the virtual program to see the #immunotherapy data we’re presenting with @Regeneron. Highlights in the video below.

Sanofi
6 days ago

With @myESMO going virtual this year, our teams are thrilled to have the opportunity to connect with oncology experts around the world as we present new research on difficult-to-treat cancers. #ESMO20 https://t.co/hK1RoTnF1n

Sanofi
6 days ago
Late-Breaking #ESMO20 News: with @Regeneron, today we shared pivotal trial data for an investigational #immunotherapy in locally advanced #BasalCell #Carcinoma (BCC). 
Learn more: https://t.co/PEetaDaoOa https://t.co/GhY95Mi3lw

Late-Breaking #ESMO20 News: with @Regeneron, today we shared pivotal trial data for an investigational #immunotherapy in locally advanced #BasalCell #Carcinoma (BCC). Learn more: https://t.co/PEetaDaoOa https://t.co/GhY95Mi3lw

Sanofi
6 days ago
Today, Dr. Jean-Christophe Rufin joins the #SanofiEspoir Foundation as President. His experience as both a physician and diplomat will enable the Foundation to further their response to health distress among vulnerable populations. 
https://t.co/0YFr2QdPsL https://t.co/lQMcTiW2wI

Today, Dr. Jean-Christophe Rufin joins the #SanofiEspoir Foundation as President. His experience as both a physician and diplomat will enable the Foundation to further their response to health distress among vulnerable populations. https://t.co/0YFr2QdPsL https://t.co/lQMcTiW2wI

Next Page